EA201791734A1 - Способ лечения воспалительных заболеваний - Google Patents
Способ лечения воспалительных заболеванийInfo
- Publication number
- EA201791734A1 EA201791734A1 EA201791734A EA201791734A EA201791734A1 EA 201791734 A1 EA201791734 A1 EA 201791734A1 EA 201791734 A EA201791734 A EA 201791734A EA 201791734 A EA201791734 A EA 201791734A EA 201791734 A1 EA201791734 A1 EA 201791734A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- inflammatory diseases
- treating inflammatory
- spa
- treating
- spondylarthritis
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 abstract 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 abstract 1
- 208000007156 Spondylarthritis Diseases 0.000 abstract 1
- 201000002661 Spondylitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Abstract
Настоящее изобретение в целом относится к способам лечения связанных с IL-23 заболеваний, в особенности, воспалительных заболеваний, таких как псориаз, псориатический артрит или аксиальный (спинальный) спондилоартрит (ax-SpA), включая анкилозирующий спондилит и нерадиографический ax-SpA, используя анти-IL-23А антитела.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562111731P | 2015-02-04 | 2015-02-04 | |
US201562130876P | 2015-03-10 | 2015-03-10 | |
US201562135335P | 2015-03-19 | 2015-03-19 | |
US201562145764P | 2015-04-10 | 2015-04-10 | |
US201562204520P | 2015-08-13 | 2015-08-13 | |
US201562235631P | 2015-10-01 | 2015-10-01 | |
PCT/US2016/016061 WO2016126638A1 (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201791734A1 true EA201791734A1 (ru) | 2018-01-31 |
Family
ID=55453266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201791734A EA201791734A1 (ru) | 2015-02-04 | 2016-02-02 | Способ лечения воспалительных заболеваний |
Country Status (15)
Country | Link |
---|---|
US (1) | US20160222102A1 (ru) |
EP (1) | EP3253794A1 (ru) |
JP (5) | JP6758304B2 (ru) |
KR (1) | KR20170120616A (ru) |
CN (2) | CN107206081A (ru) |
AU (2) | AU2016215535B2 (ru) |
BR (1) | BR112017014684A2 (ru) |
CA (1) | CA2972995A1 (ru) |
CL (1) | CL2017001960A1 (ru) |
EA (1) | EA201791734A1 (ru) |
IL (2) | IL307578A (ru) |
MX (3) | MX2017010037A (ru) |
PH (1) | PH12017501378A1 (ru) |
SG (2) | SG11201705728RA (ru) |
WO (1) | WO2016126638A1 (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3017116A1 (en) | 2010-11-04 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Anti-il-23 antibodies |
ES2908474T3 (es) | 2012-05-03 | 2022-04-29 | Boehringer Ingelheim Int | Anticuerpos anti-IL-23p19 |
EP3708679A1 (en) | 2014-07-24 | 2020-09-16 | Boehringer Ingelheim International GmbH | Biomarkers useful in the treatment of il-23a related diseases |
TWI711629B (zh) | 2014-09-03 | 2020-12-01 | 德商包林格因蓋爾漢國際股份有限公司 | 靶向IL-23A與TNF-α之化合物及其用途 |
EA201791734A1 (ru) * | 2015-02-04 | 2018-01-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Способ лечения воспалительных заболеваний |
MX2018012410A (es) * | 2016-04-15 | 2019-02-21 | Boehringer Ingelheim Int | Metodos para tratar enfermedades inflamatorias. |
EP3519049A4 (en) * | 2016-09-30 | 2020-05-27 | Janssen Biotech, Inc. | SAFE AND EFFICIENT METHOD FOR TREATING PSORIASIS WITH ANTI-IL23-SPECIFIC ANTIBODY |
CN106778030B (zh) * | 2017-01-10 | 2023-04-07 | 广州和康医疗技术有限公司 | 一种强直性脊柱炎病情监测管理系统及其监测管理方法 |
MA55149A (fr) | 2018-11-20 | 2021-09-29 | Janssen Biotech Inc | Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23 |
CN111378045B (zh) * | 2018-12-28 | 2022-08-02 | 长春金赛药业有限责任公司 | 二价双特异性抗体及其制备方法、编码基因、宿主细胞、组合物 |
TW202123965A (zh) * | 2019-09-09 | 2021-07-01 | 德商百靈佳殷格翰國際股份有限公司 | 抗-il-23p19抗體調配物 |
WO2023144699A1 (en) * | 2022-01-25 | 2023-08-03 | Sun Pharmaceutical Industries Limited | Methods for treatment of subjects with plaque psoriasis of the scalp |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
ATE135397T1 (de) | 1988-09-23 | 1996-03-15 | Cetus Oncology Corp | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
JP4124480B2 (ja) | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
EP0752248B1 (en) | 1992-11-13 | 2000-09-27 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
TR201902033T4 (tr) | 2005-06-30 | 2019-03-21 | Janssen Biotech Inc | Anti-IL-23 antikorları, bileşimleri, yöntemleri ve kullanımları. |
EA013506B1 (ru) | 2005-08-25 | 2010-06-30 | Эли Лилли Энд Компани | Антитело к il-23 и его применение |
US7807160B2 (en) | 2005-08-31 | 2010-10-05 | Schering Corporation | Engineered anti-IL-23 antibodies |
MX2008008621A (es) | 2005-12-29 | 2008-11-27 | Centocor Inc | Anticuerpos anti-il-23 humanos, composiciones, metodos y usos. |
HUE042172T2 (hu) | 2007-02-23 | 2019-06-28 | Merck Sharp & Dohme | Genetikailag elõállított anti-il-23P19 antitestek |
CA3017116A1 (en) | 2010-11-04 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Anti-il-23 antibodies |
ES2908474T3 (es) * | 2012-05-03 | 2022-04-29 | Boehringer Ingelheim Int | Anticuerpos anti-IL-23p19 |
ES2729603T3 (es) * | 2012-06-27 | 2019-11-05 | Merck Sharp & Dohme | Anticuerpos IL-23 antihumanos cristalinos |
AU2014238148A1 (en) * | 2013-03-15 | 2015-10-08 | Amgen Inc. | Methods for treating psoriasis using an anti-IL-23 antibody |
EA201791734A1 (ru) * | 2015-02-04 | 2018-01-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Способ лечения воспалительных заболеваний |
JP7090014B2 (ja) * | 2018-11-07 | 2022-06-23 | 株式会社ミツバ | ロータ、モータ、ブラシレスワイパーモータ及びロータの製造方法 |
-
2016
- 2016-02-02 EA EA201791734A patent/EA201791734A1/ru unknown
- 2016-02-02 US US15/013,008 patent/US20160222102A1/en active Pending
- 2016-02-02 JP JP2017541030A patent/JP6758304B2/ja active Active
- 2016-02-02 KR KR1020177024896A patent/KR20170120616A/ko not_active Application Discontinuation
- 2016-02-02 WO PCT/US2016/016061 patent/WO2016126638A1/en active Application Filing
- 2016-02-02 AU AU2016215535A patent/AU2016215535B2/en active Active
- 2016-02-02 CN CN201680008402.3A patent/CN107206081A/zh active Pending
- 2016-02-02 CN CN202110769475.7A patent/CN113559258A/zh active Pending
- 2016-02-02 SG SG11201705728RA patent/SG11201705728RA/en unknown
- 2016-02-02 EP EP16707997.9A patent/EP3253794A1/en active Pending
- 2016-02-02 IL IL307578A patent/IL307578A/en unknown
- 2016-02-02 SG SG10202103879YA patent/SG10202103879YA/en unknown
- 2016-02-02 BR BR112017014684A patent/BR112017014684A2/pt active Search and Examination
- 2016-02-02 CA CA2972995A patent/CA2972995A1/en active Pending
- 2016-02-02 MX MX2017010037A patent/MX2017010037A/es unknown
-
2017
- 2017-06-22 IL IL253118A patent/IL253118A0/en unknown
- 2017-08-01 CL CL2017001960A patent/CL2017001960A1/es unknown
- 2017-08-01 PH PH12017501378A patent/PH12017501378A1/en unknown
- 2017-08-03 MX MX2022006575A patent/MX2022006575A/es unknown
- 2017-08-03 MX MX2022006573A patent/MX2022006573A/es unknown
-
2020
- 2020-04-27 JP JP2020078179A patent/JP7042298B2/ja active Active
- 2020-04-27 JP JP2020078178A patent/JP7042297B2/ja active Active
- 2020-04-27 JP JP2020078177A patent/JP7044824B2/ja active Active
-
2021
- 2021-12-16 AU AU2021286378A patent/AU2021286378A1/en active Pending
-
2022
- 2022-03-17 JP JP2022042417A patent/JP2022081644A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2018505882A (ja) | 2018-03-01 |
CL2017001960A1 (es) | 2018-04-20 |
AU2016215535B2 (en) | 2021-09-16 |
JP7042298B2 (ja) | 2022-03-25 |
CN107206081A (zh) | 2017-09-26 |
CA2972995A1 (en) | 2016-08-11 |
JP7044824B2 (ja) | 2022-03-30 |
US20160222102A1 (en) | 2016-08-04 |
IL253118A0 (en) | 2017-08-31 |
AU2021286378A1 (en) | 2022-01-20 |
JP2020125338A (ja) | 2020-08-20 |
BR112017014684A2 (pt) | 2018-01-09 |
JP2022081644A (ja) | 2022-05-31 |
MX2022006575A (es) | 2022-07-11 |
KR20170120616A (ko) | 2017-10-31 |
MX2017010037A (es) | 2018-05-15 |
JP6758304B2 (ja) | 2020-09-23 |
JP2020125340A (ja) | 2020-08-20 |
JP2020125339A (ja) | 2020-08-20 |
IL307578A (en) | 2023-12-01 |
MX2022006573A (es) | 2022-07-11 |
CN113559258A (zh) | 2021-10-29 |
SG11201705728RA (en) | 2017-08-30 |
AU2016215535A1 (en) | 2017-07-13 |
EP3253794A1 (en) | 2017-12-13 |
SG10202103879YA (en) | 2021-05-28 |
PH12017501378A1 (en) | 2018-01-08 |
JP7042297B2 (ja) | 2022-03-25 |
WO2016126638A1 (en) | 2016-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201791734A1 (ru) | Способ лечения воспалительных заболеваний | |
EA201890630A1 (ru) | Антитела против pd-1 и способы их применения | |
EA201891201A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890050A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201991862A1 (ru) | Композиции и способы, предназначенные для лечения гемоглобинопатий | |
EA201890049A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201891199A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201891532A1 (ru) | Композиции и способы лечения гемоглобинопатий | |
EA201791867A1 (ru) | Бициклические гетероциклы как ингибиторы fgfr4 | |
EA201890048A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201890047A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201792573A1 (ru) | Триспецифические связанные белки и способы их применения | |
EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
EA201791768A1 (ru) | Иммуномодулирующие агенты | |
EA201791422A1 (ru) | Фармацевтические продукты и устойчивые жидкие композиции антител к il-17 | |
EA201691610A8 (ru) | Анти-jagged1 антитела и способы применения | |
PH12018500578A1 (en) | Methods of treating inflammatory diseases | |
MX2020006365A (es) | Quinazolinonas como inhibidores de poli(adenosin difosfato-ribosa)polimerasa 14 (parp14). | |
BR112017013568A2 (pt) | compostos bicíclicos fundidos para o tratamento de doenças | |
EA201792080A1 (ru) | Гуманизированные анти-c1s антитела и способы их применения | |
EA201890572A1 (ru) | Биофармацевтические композиции | |
EA202193002A2 (ru) | Соединение, нацеленное на ил-23a и фно-альфа, и его применение | |
EA201691541A1 (ru) | Новые анти-baff антитела | |
EA201890185A1 (ru) | Способы лечения опосредованных гепсидином нарушений | |
EA201892624A1 (ru) | Растения, дающие бессемянные плоды |